22
Participants
Start Date
March 31, 2016
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Intranasal (IN) naloxone 1x
Administered as 100 μl 14.0 mg/ml (1.4 mg naloxone) by Aptar Unitdose device as one puff in one nostril
Intranasal (IN) naloxone 2
Administered as 2x 100 μl 14 mg/ml (2.8 mg naloxone) by Aptar Unitdose device as two puffs within the same nostril with 3 minutes interval
Intravenous (IV) naloxone
Administered as 1 ml Naloxon B Braun 0.4 mg/ml (0.4 mg naloxone), in an intravenous cannula in the opposite arm of which the blood samples are drawn from. IV bolus will be given rapidly (in less than 5 seconds)
Intramuscular (IM) naloxone
Naloxone administered as 2 ml Naloxon B Braun 0.4 mg/ml (0.8 mg naloxone) in a Braun Omnifix 2.5 ml syringe using a BD Microlance 3 21G (green) 0.8x40 mm needle in the deltoid muscle of the non-dominant arm
Department of Circulation and Medical Imaging, Trondheim
St. Olavs Hospital
OTHER
A/S Den norske Eterfabrikk
INDUSTRY
Smerud Medical Research International AS
OTHER
Norwegian University of Science and Technology
OTHER